Sandeep Chitnis, Honorary National Secretary of the Multiple Sclerosis Society of India (MSSI), provides valuable information on the availability of DMTs in India and the challenges in accessing them. In addition, he suggests ways in which the MSSI can utilise the WHO's Essential Medicine List to advocate for People with MS.